281 related articles for article (PubMed ID: 17166989)
1. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast.
Kraft M; Cairns CB; Ellison MC; Pak J; Irvin C; Wenzel S
Chest; 2006 Dec; 130(6):1726-32. PubMed ID: 17166989
[TBL] [Abstract][Full Text] [Related]
2. Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study.
Gao JM; Cai F; Peng M; Ma Y; Wang B
Chin Med J (Engl); 2013 Jun; 126(12):2229-34. PubMed ID: 23786930
[TBL] [Abstract][Full Text] [Related]
3. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
4. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
5. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
Robinson DS; Campbell D; Barnes PJ
Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
[TBL] [Abstract][Full Text] [Related]
6. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
7. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
Barnes N; Wei LX; Reiss TF; Leff JA; Shingo S; Yu C; Edelman JM
Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
[TBL] [Abstract][Full Text] [Related]
9. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
[TBL] [Abstract][Full Text] [Related]
10. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ
Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382
[TBL] [Abstract][Full Text] [Related]
11. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
Gaszczyk G; Latoś T; Słowikowski A; Janiak B
Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of montelukast in the treatment of cough variant asthma.
Spector SL; Tan RA
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
[TBL] [Abstract][Full Text] [Related]
14. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
[TBL] [Abstract][Full Text] [Related]
15. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.
Zhang J; Yu C; Noonan G; Reiss TF
Clin Ther; 2002 Apr; 24(4):574-82. PubMed ID: 12017402
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma.
American Lung Association Asthma Clinical Research Centers
Am J Respir Crit Care Med; 2007 Feb; 175(3):235-42. PubMed ID: 16998094
[TBL] [Abstract][Full Text] [Related]
17. Effect of montelukast on peripheral airflow obstruction in children with asthma.
Spahn JD; Covar RA; Jain N; Gleason M; Shimamoto R; Szefler SJ; Gelfand EW
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):541-9. PubMed ID: 16680924
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.
Dockhorn RJ; Baumgartner RA; Leff JA; Noonan M; Vandormael K; Stricker W; Weinland DE; Reiss TF
Thorax; 2000 Apr; 55(4):260-5. PubMed ID: 10722763
[TBL] [Abstract][Full Text] [Related]
19. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol.
Brannan JD; Anderson SD; Gomes K; King GG; Chan HK; Seale JP
Am J Respir Crit Care Med; 2001 May; 163(6):1420-5. PubMed ID: 11371412
[TBL] [Abstract][Full Text] [Related]
20. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
Bateman ED; Goehring UM; Richard F; Watz H
J Allergy Clin Immunol; 2016 Jul; 138(1):142-149.e8. PubMed ID: 26915674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
